
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves First At-Home Starting Dose for Leqembi in Early Alzheimer Disease
2
Medicare GLP-1 Bridge Program Looking to Expand Medication Access
3
Q&A: How AI Is Reshaping the Pharmacist's Role in Medication Safety
4
Emerging Market Access Models Reshapes Drug Distribution
5































